Skip to content

Alamar Biosciences

US · ALMR #2657 by market cap Listed 2026
26.48 -2.20 -7.67%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 28.24 -1.53%
After-hours 26.50 +0.08%
38.1319.0926.482026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on ALMR?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -23.6% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 3.2% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days C → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Performance

1W -14.05%
1M -5.97%
3M -23.56%
6M +31.35%

Key statistics

Price & volume

Prev close
28.68
Open
28.25
Day range
26.24 - 28.25
Avg price
26.81
Volume
712.60K
Turnover
19.10M
Amplitude
7.01%
52-week range
18.85 - 39.61

Valuation

P/E
-49.04
P/E (TTM)
-23.01
P/B
6.06
EPS
-0.54
Net profit
-37.52M
Net assets
303.70M

Share structure

Market cap
1.84B
Float cap
1.11B
Shares out
69.48M
Float shares
41.98M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2026-04-17
52-week range 37% of range
18.85 39.61

33.1% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-5.46M net over the window

Short interest

Shares short
2.24M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Alamar Biosciences (ALMR)?

Alamar Biosciences last traded at 26.48. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Alamar Biosciences's market cap?

About 1.84B.

What is the P/E ratio of Alamar Biosciences?

The trailing twelve-month P/E is -23.01. The Valuation tab shows it against the stock's own five-year range.

Does Alamar Biosciences pay a dividend?

Alamar Biosciences does not currently pay a regular dividend.

Is Alamar Biosciences a buy according to analysts?

The consensus of 2 analysts is a Buy rating, with an average 12-month price target of 36.00, which implies 36.0% upside from the current price. This is not investment advice.

What is Alamar Biosciences's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Alamar Biosciences a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Alamar Biosciences discussion 0 comments

Add a comment